Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Matsumaru, Naoki"'
Autor:
Tajima G; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan.; Department of Regulatory Affairs, Pfizer R&D Japan G.K, Tokyo, Japan., Matsumaru N; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan., Tsukamoto K; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan.
Publikováno v:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Sep; Vol. 47 (9), pp. 1395-1401. Date of Electronic Publication: 2022 Apr 30.
Autor:
Miyazaki T; Global Regulatory Science, Gifu Pharmaceutical University., Komiyama M; Global Regulatory Science, Gifu Pharmaceutical University., Matsumaru N; Global Regulatory Science, Gifu Pharmaceutical University., Maeda H; Department of Regulatory Science, Division of Clinical Pharmacy, Meiji Pharmaceutical University., Tsukamoto K; Global Regulatory Science, Gifu Pharmaceutical University.
Publikováno v:
Biological & pharmaceutical bulletin [Biol Pharm Bull] 2022; Vol. 45 (4), pp. 477-482.
Autor:
Izuka S; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan.; Astellas Pharma Inc, Tokyo, Japan., Matsumaru N; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan., Tsukamoto K; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan.
Publikováno v:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2021 Dec; Vol. 46 (6), pp. 1582-1590. Date of Electronic Publication: 2021 Jul 11.
Autor:
Ushijima S; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan. satoshi.ushijima@astellas.com.; Astellas Pharma Inc., Tokyo, Japan. satoshi.ushijima@astellas.com., Matsumaru N; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan., Tsukamoto K; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan.
Publikováno v:
Pharmaceutical medicine [Pharmaceut Med] 2021 Jul; Vol. 35 (4), pp. 253-260. Date of Electronic Publication: 2021 Jul 22.
Autor:
Nakayama H; Healthcare Policy & CSR, Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan. hiroki.nakayama@astellas.com., Matsumaru N; Global Regulatory Science, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu, 501-1196, Japan., Tsukamoto K; Global Regulatory Science, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu, 501-1196, Japan.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2019 Oct; Vol. 37 (5), pp. 1086-1093. Date of Electronic Publication: 2018 May 31.
Autor:
Rokuda M; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan; Japan-Asia Clinical Development 1, Development, Astellas Pharma Inc., Tokyo, Japan. Electronic address: mitsuhiro.rokuda@astellas.com., Matsumaru N; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan., Tsukamoto K; Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan.
Publikováno v:
Clinical therapeutics [Clin Ther] 2018 Feb; Vol. 40 (2), pp. 284-295. Date of Electronic Publication: 2018 Feb 01.
Publikováno v:
Journal of Clinical Pharmacy & Therapeutics. Sep2022, Vol. 47 Issue 9, p1388-1394. 7p.
Autor:
Hino, Yoshitsugu, Okada, Miu, Hallgreen, Christine Erikstrup, De Bruin, Marie Louise, Doty, Randell E, Matsumaru, Naoki, Tsukamoto, Katsura, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Biological and Pharmaceutical Bulletin, 46(5), 700. Pharmaceutical Society of Japan
A cancer diagnosis is devastating for both patients and their caregivers. With high morbidity and mortality, cancer is a serious disease area with unmet medical needs. Thus, innovative anticancer drugs are in high demand worldwide but are unequally a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57449fb52f5d124df4b06c960cbed93
https://dspace.library.uu.nl/handle/1874/428433
https://dspace.library.uu.nl/handle/1874/428433
Autor:
Tsukamoto, Katsura1 (AUTHOR) tsukamoto@gifu-pu.ac.jp, Cnop, Miriam2 (AUTHOR), Mori, Daichi1 (AUTHOR), Kume, Shoen3 (AUTHOR), Anazawa, Takayuki4 (AUTHOR), Doi, Masako5 (AUTHOR), Chikazawa, Kazuhiko6 (AUTHOR), Matsumaru, Naoki1 (AUTHOR)
Publikováno v:
Therapeutic Innovation & Regulatory Science. Jul2019, Vol. 53 Issue 4, p535-541. 7p.
Publikováno v:
Therapeutic Innovation & Regulatory Science. Mar2019, Vol. 53 Issue 2, p199-206. 8p.